RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2001; 85(02): 193-194
DOI: 10.1055/s-0037-1615674
DOI: 10.1055/s-0037-1615674
Commentary
MHC Class II and III Polymorphisms and the Antiphospholipid Syndrome
Autoren
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
08. Dezember 2017 (online)
-
References
- 1 Godfrey T, D’Cruz D. Antiphospholipid syndrome: general features. In: Khamashta MA. (ed). Hughes’ syndrome. London: Springer; 2000: 8-19.
- 2 Asherson RA. A “primary” antiphospholipid syndrome?. J Rheumatol 1988; 15: 1742-6.
- 3 Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, Fernandez L, Ponce de Leon S. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. Medicine 1989; 68: 353-65.
- 4 Wilson WA, Gharavi AE. Genetic risk factors for aPL syndrome. Lupus 1996; 5: 398-403.
- 5 Galli M, Bevers EM, Barbui T. Immunologic properties and anticoagulant activities of antiphospholipid antibodies. In: Levine SR, Brey RL. (eds). Clinical Approach to Antiphospholipid Antibodies. Boston: Butterworth Heinemann; 2000: 19-41.
- 6 Hartung K, Coldewey R, Corvetta A, Deicher H, Kalden JR, Krapf F, Lang B, Lakomek Hj, Leidvogel B, Peter HH. MHC gene products and anti-cardiolipin antibodies in systemic lupus erythematosus. Results of a multi-center study. Autoimmunity 1992; 13: 95-9.
- 7 Asherson RA, Doherty DG, Vergani D, Khamashta MA, Hughes GRV. Major histocompatibility complex associations with primary antiphospholipid syndrome. Arthritis Rheum 1992; 35: 124-5.
- 8 Arnett FC, Olsen ML, Anderson KL, Reveille JD. Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J Clin Invest 1991; 87: 1490-5.
- 9 Arnett FC, Thiagarajan P, Ahn C, Reveille JD. Association of anti-β2-glycoprotein I autoantibodies with HLA class II alleles in three ethnic groups. Arthritis Rheum 1999; 42: 268-74.
- 10 Wilson WA, Scopelitis E, Machalski JP, Pierangeli SS, Silvera LH, Elston RC, Harris EN. Familial anticardiolipin antibodies and C4 deficiency geno-types that coexist with MHC DQB1 risk factors. J Rheumatol 1995; 22: 227-35.
- 11 Arvieux J, Roussel B, Ponard D, Colomb MG. IgG2 subclass restriction of anti-β2-glycoprotein I antibodies in autoimmune patients. Clin Exp Immunol 1994; 95: 310-5.
- 12 Galli M, Comfurius P, Barbui T, Zwaal RFA, Bevers EM. Anticoagulant activity of β2-glycoprotein I is potentiated by a distinct subgroup of anti-cardiolipin antibodies. Thromb Haemost 1992; 68: 297-300.
- 13 Bertolaccini ML, Atsumi T, Caliz AR, Amengual O, Khamashta MA, Hughes GR, Koike T. Association of antiphosphatidylserine/prothrombin autoantibodies with HLA class II genes. Arthritis Rheum 2000; 43: 683-8.
- 14 Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, Van der Vanden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
- 15 Galli M, Finazzi G, Duca F, Norbis F, Moia M. The G1691A mutation of factor V, but not the G20210A mutation of factor II or the C677T mutation of methylenetetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants. Br J Haematol 2000; 108: 865-70.
- 16 Ruiz-Arguelles GJ, Ruiz-Arguelles A, Alarcon-Segovia D, Drenkard C, Villa A, Cabiedes J, Presno-Bernal M, Deleze M, Ortiz-Lopez R, Vazquez-Prado J. Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thrombosis, antiphospholipid antibodies, and the antiphospholipid syndrome. J Rheumatol 1991; 18: 552-8.
- 17 Comp P, Esmon C. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984; 311: 1525-7.
- 18 Hessing M. The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system. Biochem J 1991; 277: 581-92.
- 19 Bertolaccini ML, Atsumi T, Lanchbury JS, Caliz AR, Katsumata K, Vaughan RW, Kondeatis E, Khamashta MA, Koike T, Hughes GRV. Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome. Thromb Haemost 2001; 85: 198-203.
- 20 Vassalli P. The pathophysiology of tumor necrosis factor. Ann Rev Immunol 1992; 10: 411-52.
- 21 Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G, Wordsworth P. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 1996; 23: 1725-8.